August 11, 2025: The FDA voices concern about sites that supply compounding ingredients Partnership for Safe Medicines The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and clinics. With BPC 157, TB 500, and others under 503A review, questions around compounding, compliance, and what is Compounded "semaglutide" is not FDA approved semaglutide.com FDA considers adding a dozen peptides to its bulk drug compounding list RAPS Peptide Therapy in Boise Specialized Treatment for First Responders Blueline Wellness FDA Peptide Update: Category 2 Removals Explained